Horizon Pharma (HZNP) Misses Q1 EPS by 2c, Lowers Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. MA
9. FND
10. DASH

Go back to Horizon Pharma (HZNP) Misses Q1 EPS by 2c, Lowers Outlook

Horizon Pharma (HZNP) PT Lowered to $13 at Citi; Remains Positive on Orphan Drug Valuation and Primary Care Earnings

May 9, 2017 7:40 AM EDT

Citi lowered its price target on Horizon Pharma (NASDAQ: HZNP) to $13.00 (from $20.00) while maintaining a Buy rating.

Analyst Liav Abraham said results highlight the structural challenges associated with the companys primary care franchise and they acknowledge the limited visibility.

That... More

Mizuho Securities Downgrades Horizon Pharma (HZNP) to Neutral

May 9, 2017 5:21 AM EDT

Mizuho Securities downgraded Horizon Pharma (NASDAQ: HZNP) from Buy to Neutral with a price target of $10.00 (from $22.00).

Analyst Irina Koffler cites uncertainty revolving around primary business and the lack of guidance conviction for her downgrade.

FY 2017 EPS estimate falls from $2.11 to $0.66... More